People · Operator
Named in public records as an officer, director or promoter · active 2019–2023 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vigil Neuroscience, Inc. | — | Pharmaceuticals | Series C | $215.0M | $1.3B | 2021 |
| Volastra Therapeutics, Inc. | — | Biotechnology | Series C | $105.3M | $170.5M | 2023 |
| Praxis Precision Medicines, Inc. | — | Pharmaceuticals | Series B | $31.9M | $340.0M | 2019 |
Stefan Vitorovic at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stefan Vitorovic on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bruce Booth | 1 | 12 |
| Amy Schulman | 1 | 11 |
| Clay Thorp | 1 | 10 |
| Nicholas Galakatos | 1 | 6 |
| Robert Mittendorff | 1 | 5 |
| David Nicholson | 1 | 5 |
| Thomas Dyrberg | 1 | 5 |
| Shaan Gandhi | 1 | 4 |
| Luc Dochez | 1 | 4 |
| WILLIAM D. YOUNG | 1 | 4 |
| William Young | 1 | 3 |
| David Southwell | 1 | 3 |
| Ellie McGuire | 1 | 2 |
| Sandra Peterson | 1 | 2 |
| Mary Thistle | 1 | 2 |
| Cheryl Blanchard | 1 | 2 |
| Alfred Sandrock | 1 | 2 |
| Jennifer Ziolkowski | 1 | 2 |
| Suzanne Bruhn | 1 | 2 |
| Nicholas G. Galakatos | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.